Clinical Trials Browser

Phase 1 × Genital Neoplasms, Female × nintedanib × Clear all

NCT02182245 2025-01-23

Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies

Phase 1 Completed

Genital Neoplasms, Female